Practice-Changing Regorafenib Data at 2018 GI Cancers Symposium Practice-Changing Regorafenib Data at 2018 GI Cancers Symposium
Dr John Marshall discusses new science in pancreatic and colorectal cancers, presented at the 2018 Gastrointestinal Cancers Symposium.Medscape Oncology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - January 31, 2018 Category: Consumer Health News Tags: Hematology-Oncology Commentary Source Type: news

New Pattern in Gastric Cancer: One Type Increasing in US New Pattern in Gastric Cancer: One Type Increasing in US
One type of gastric cancer is on the increase, especially among individuals younger than 50 years. Women are more at risk than men.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - January 31, 2018 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

FDA Acts to Stem Misuse, Abuse of Antidiarrheal Loperamide FDA Acts to Stem Misuse, Abuse of Antidiarrheal Loperamide
The FDA moves to limit the number of loperamide doses per package amid ongoing reports of serious cardiac problems and deaths with misuse and abuse of the antidiarrhea medication.News Alerts (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - January 30, 2018 Category: Consumer Health News Tags: Gastroenterology News Alert Source Type: news

Predicting IBD Treatment Responders at ECCO 2018 Predicting IBD Treatment Responders at ECCO 2018
Questions about inflammatory bowel disease (IBD) will be answered in presentations at the upcoming European Crohn's and Colitis Organisation (ECCO) 2018 Congress.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - January 30, 2018 Category: Consumer Health News Tags: Gastroenterology News Source Type: news

FDA Moves to Limit Loperamide Doses per Package
(MedPage Today) -- Aimed at discouraging use of the drug to ease opioid withdrawal symptoms (Source: MedPage Today Gastroenterology)
Source: MedPage Today Gastroenterology - January 30, 2018 Category: Gastroenterology Source Type: news

New computational method reveals chemoresistance drug targets
(Osaka University) The methylation of deoxycytosine to form 5-methylcytosine (5mC) is an important feature of cancer. Extensive DNA methylation and transcription analyses have provided large quantities of data, but it is challenging to identify critical genes related to cancer development from these data. Osaka University researchers developed a new mathematical method to extract appropriate information from the data, and successfully identified the gene TRAF4 as a key candidate for conferring resistance to anti-cancer drugs in gastrointestinal cancer. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - January 30, 2018 Category: Cancer & Oncology Source Type: news

Regulators Trying to Reduce Physician Burden Linked to EHR
Agency head describes the multifactorial burden, which is being addressed on different levels (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - January 30, 2018 Category: Cancer & Oncology Tags: Cardiology, Dermatology, Endocrinology, Family Medicine, Geriatrics, Gastroenterology, Gynecology, Infections, AIDS, Internal Medicine, Allergy, Critical Care, Emergency Medicine, Nephrology, Neurology, Nursing, Oncology, Ophthalmology, Orthopedics, ENT, Source Type: news

How Moffitt helped develop a drug to treat the kind of cancer that killed Steve Jobs
A Moffitt Cancer Center physician was the lead investigator in a clinical trial for a just-approved drug to treat a type of cancer that affects the pancreas or gastrointestinal tract. It’s the first time a radioactive drug has been approved for the treatment of gastroenteropancreatic neuroendocrine tumors, the U.S. Food and Drug Administration said in a Jan. 26 news release announcing approval of the drug, named Lutathera. There are about 7 cases of these tumors per 100,000 people in the United… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - January 29, 2018 Category: Pharmaceuticals Authors: Margie Manning Source Type: news

Pre - Op Physical Therapy May Cut Pulmonary Complications
Patients undergoing elective upper abdominal surgery may benefit from breathing exercise training (Source: Pulmonary Medicine News - Doctors Lounge)
Source: Pulmonary Medicine News - Doctors Lounge - January 29, 2018 Category: Respiratory Medicine Tags: Cardiology, Gastroenterology, Nephrology, Pathology, Pulmonology, Surgery, Journal, Source Type: news

Health Care Spending Up, Mainly Due to Rising Prices
Spending increasing despite no change or decline in utilization of most health care services (Source: The Doctors Lounge - Psychiatry)
Source: The Doctors Lounge - Psychiatry - January 29, 2018 Category: Psychiatry Tags: Cardiology, Dermatology, Endocrinology, Family Medicine, Geriatrics, Gastroenterology, Gynecology, Infections, AIDS, Internal Medicine, Allergy, Critical Care, Emergency Medicine, Nephrology, Neurology, Nursing, Oncology, Ophthalmology, Orthopedics, ENT, Source Type: news

Advanced Accelerator Applications receives FDA approval for Lutathera ® for treatment of gastroenteropancreatic neuroendocrine tumors
Novartis AG (NYSE: NVS) announced that Advanced Accelerator Applications, a subsidiary of Novartis Groupe S.A., has received US Food and Drug Administration (FDA) approval of its new drug application (NDA) for Lutathera® (lutetium Lu 177 dotatate*) for the treatment of somatostatin receptor positive gastroenteropancreatic neuroendocrine tumors (GEP-NETs), including foregut, midgut, and hindgut neuroendocrine tumors, in adults. (Source: World Pharma News)
Source: World Pharma News - January 29, 2018 Category: Pharmaceuticals Tags: Featured Novartis Business and Industry Source Type: news

Lutathera Approved for Some Gastro and Pancreatic Cancers
Title: Lutathera Approved for Some Gastro and Pancreatic CancersCategory: Health NewsCreated: 1/26/2018 12:00:00 AMLast Editorial Review: 1/29/2018 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - January 29, 2018 Category: Cancer & Oncology Source Type: news

HBV Reactivation in Patients With HCV/HBV Cirrhosis on DAAs HBV Reactivation in Patients With HCV/HBV Cirrhosis on DAAs
Does clearance or suppression of HCV by direct-acting antivirals in patients with chronic HCV hepatitis and HBV coinfection increase the risk of HBV reactivation?Journal of Viral Hepatitis (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - January 29, 2018 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

Bevacizumab dramatically improves severe hereditary hemorrhagic telangiectasia (HHT) associated bleeding
(Elsevier) Patients with hereditary hemorrhagic telangiectasia (HHT) with severe bleeding, who were treated with intravenous bevacizumab, reported a marked reduction in nose bleeds and gastrointestinal bleeding and were able to stop or considerably reduce blood transfusions, resulting in significantly improved quality of life. A new study published in Mayo Clinic Proceedings provides good quality evidence for the excellent safety profile and efficacy of intravenous bevacizumab in the management of these patients. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - January 29, 2018 Category: International Medicine & Public Health Source Type: news

No Survival Benefit with Bevacizumab Maintenance in CRC (CME/CE)
(MedPage Today) -- Monotherapy no better than observation after induction chemo (Source: MedPage Today Gastroenterology)
Source: MedPage Today Gastroenterology - January 28, 2018 Category: Gastroenterology Source Type: news

Is The ‘ Souping ’ Trend For You?
 By Lisa Drayer, CNN (CNN) — When I first heard of “souping,” it brought me back to my clinical days working in a hospital, where pureed soups and other easy to digest foods — also known as “full liquids” — would be prescribed for patients recovering from gastrointestinal surgery, or those who had difficulty chewing or swallowing. Then I reflected upon how much I regularly enjoy soup, especially for the comfort it provides on cold, dreary days — even though, thankfully, I have no health issues that would require such an easily digestible meal. Soup is often my go-to in t...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - January 28, 2018 Category: Consumer Health News Authors: Health – CBS Boston Tags: Health News CNN Diets Source Type: news

Parasite mimics human proteins to provide 'ready meals' from the gut
(University of East Anglia) Giardia parasites -- responsible for one of the world's most common gastric diseases -- mimic human cell functions to break apart cells in the gut and feed off them.The secret behind giardia's success has eluded scientists for more than 300 years.Researchers found that the parasite produces two types of protein that enable it to cut through layers of protective mucus in the gut, breaking the links that knit cells together to access the nutrients within them. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - January 28, 2018 Category: International Medicine & Public Health Source Type: news

Weight loss breakthrough - Diet plan to help you lose more than 2 stone in three months
WEIGHT loss diets can feel like an ordeal, but a new surgery-free gastric balloon could help you shed about 14kg on average, after just three months. (Source: Daily Express - Health)
Source: Daily Express - Health - January 27, 2018 Category: Consumer Health News Source Type: news

Odds of Post - Op Mortality Increase As Weekend Approaches
Mortality after elective surgery increases in graded manner as day of surgery approaches weekend (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - January 27, 2018 Category: Cancer & Oncology Tags: Cardiology, Family Medicine, Geriatrics, Gastroenterology, Gynecology, Nephrology, Oncology, Ophthalmology, Orthopedics, ENT, Rheumatology, Surgery, Anesthesiology & amp; Pain, Urology, Journal, Source Type: news

Lutathera Approved for Some Gastro and Pancreatic Cancers
(Source: Cancercompass News: Colorectal Cancer)
Source: Cancercompass News: Colorectal Cancer - January 27, 2018 Category: Cancer & Oncology Source Type: news

FDA Approves Lutathera (lutetium Lu 177 dotatate) for Gastroenteropancreatic Neuroendocrine Tumors
January 26, 2018 -- The U.S. Food and Drug Administration today approved Lutathera (lutetium Lu 177 dotatate) for the treatment of a type of cancer that affects the pancreas or gastrointestinal tract called gastroenteropancreatic neuroendocrine... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - January 26, 2018 Category: Drugs & Pharmacology Source Type: news

Novel Radiopharmaceutical Approved for GEP-NETs Novel Radiopharmaceutical Approved for GEP-NETs
A novel radiopharmaceutical, lutetium Lu 177 dotatate (Lutathera), has been approved by the FDA for use in gastroenteropancreatic neuroendocrine tumors.FDA Approvals (Source: Medscape Radiology Headlines)
Source: Medscape Radiology Headlines - January 26, 2018 Category: Radiology Tags: Hematology-Oncology News Alert Source Type: news

Lutathera Approved for Some Gastro and Pancreatic Cancers
FRIDAY, Jan. 26, 2018 -- Lutathera (lutetium Lu 177 dotatate) is the first radioactive drug to be approved by the U.S. Food and Drug Administration to treat certain cancers of the gastrointestinal tract and pancreas, the agency said Friday in a news... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - January 26, 2018 Category: General Medicine Source Type: news

Plecanatide Gets FDA Nod for IBS With Constipation in Adults Plecanatide Gets FDA Nod for IBS With Constipation in Adults
Plecanatide, already approved for chronic idiopathic constipation in adults, gets FDA approval for treatment of irritable bowel syndrome (IBS) with constipation in adults.News Alerts (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - January 26, 2018 Category: Consumer Health News Tags: Gastroenterology News Alert Source Type: news

FDA approves new treatment for certain digestive tract cancers
The U.S. Food and Drug Administration today approved Lutathera (lutetium Lu 177 dotatate) for the treatment of a type of cancer that affects the pancreas or gastrointestinal tract called gastroenteropancreatic neuroendocrine tumors (GEP-NETs). This is the first time a radioactive drug, or radiopharmaceutical, has been approved for the treatment of GEP-NETs. Lutathera is indicated for adult patients with somatostatin receptor-positive GEP-NETs. (Source: World Pharma News)
Source: World Pharma News - January 26, 2018 Category: Pharmaceuticals Tags: Featured FDA Regulatory Affairs Source Type: news

Should you try 'souping'?
When I first heard of "souping," it brought me back to my clinical days working in a hospital, where pureed soups and other easy to digest foods -- also known as "full liquids" -- would be prescribed for patients recovering from gastrointestinal surgery, or those who had difficulty chewing or swallowing. (Source: CNN.com - Health)
Source: CNN.com - Health - January 26, 2018 Category: Consumer Health News Source Type: news

Survival After HCC Treatment Among Patients With/Without NAFLD Survival After HCC Treatment Among Patients With/Without NAFLD
This study aimed to identify overall survival differences after receipt of curative treatment for NAFLD and non-NAFLD-HCC, stratified by curative treatment modality.Alimentary Pharmacology & Therapeutics (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - January 26, 2018 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

Swallowed button batteries add to safety concerns about 'fidget spinners'
(Wolters Kluwer Health) A report of two young children with burns of the esophagus caused by swallowed button batteries from 'fidget spinners' highlights a risk of severe injuries involving these popular toys, according to a series of reports in the January/February Journal of Pediatric Gastroenterology and Nutrition (JPGN). Official journal of the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition (NASPGHAN) and the European Society for Paediatric Gastroenterology, Hepatology and Nutrition, JPGN is published by Wolters Kluwer. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - January 26, 2018 Category: International Medicine & Public Health Source Type: news

BU researcher awarded NIH grant to continue research on non-alcoholic fatty liver disease
(Boston University School of Medicine) Michelle T. Long, MD, assistant professor of medicine at Boston University School of Medicine (BUSM) and a gastroenterologist at Boston Medical Center (BMC), recently was a awarded nearly $1 million dollars from the National Institutes of Diabetes and Digestive and Kidney Diseases (NIDDK) of the National Institutes of Health (NIH). The five-year grant will continue to fund her research on non-alcoholic fatty liver disease (NAFLD). (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - January 26, 2018 Category: International Medicine & Public Health Source Type: news

Gene therapy using CAR T cells could provide long-term protection against HIV
FINDINGSA UCLA-led research team has created blood-forming stem cells that can carry a gene that allows the body to produce cells that can detect and destroy HIV-infected cells. The blood-forming cells, called hematopoietic stem and progenitor cells, or HSPCs, have been engineered to carry chimeric antigen receptor, or CAR, genes that allows the production of immune cells that target cells infected with HIV.After being transplanted into the body, the engineered cells formed immune cells that not only destroyed the infected cells, but also lived for more than two years. This suggests that they have the potential to give peo...
Source: UCLA Newsroom: Health Sciences - January 25, 2018 Category: Universities & Medical Training Source Type: news

OncoBreak: What Makes a Good Doctor? Guide to Lymphedema; Depression and Cancer
(MedPage Today) -- News, features, and commentary about cancer-related issues (Source: MedPage Today Gastroenterology)
Source: MedPage Today Gastroenterology - January 25, 2018 Category: Gastroenterology Source Type: news

No Benefit With Bevacizumab Maintenance Therapy for Metastatic CRC During Chemo-Free Intervals
Adding bevacizumab maintenance therapy failed to improve outcomes compared with no treatment when administered during chemotherapy-free intervals to patients with metastatic colorectal cancer after induction chemotherapy. (Source: CancerNetwork)
Source: CancerNetwork - January 25, 2018 Category: Cancer & Oncology Authors: Dave Levitan Tags: Colorectal Cancer Gastrointestinal Cancer News Source Type: news

Exercise can cause acid reflux - avoid this drink to lower risk of heartburn symptoms
EXERCISE, and the resulting weight loss, can be a good way to help prevent gastrointestinal issues. But, for some people, certain forms of exercise can have an unpleasant side effect - heartburn. (Source: Daily Express - Health)
Source: Daily Express - Health - January 25, 2018 Category: Consumer Health News Source Type: news

Chemotherapy for advanced gastric cancer
Data from 64 RCTs in this Cochrane Review concludes chemotherapy improves survival (by additional 6.7months) compared to best supportive care, and combination chemotherapy improves survival (by an additional month) compared to single-agent 5-fluorouracil. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - January 25, 2018 Category: Consumer Health News Source Type: news

Robotic or Lap Surgery for Ventral Hernias? General Surgery News Report
(MedPage Today) -- Also, decision-making for parastomal hernias (Source: MedPage Today Gastroenterology)
Source: MedPage Today Gastroenterology - January 25, 2018 Category: Gastroenterology Source Type: news

Can You Inject Without the Needle?
Patients aren’t typically thrilled by the prospect of needles, and sharps can pose hazards for patients and caretakers. So, could an injectable device be developed without a needle? Andrew Coats, senior director of engineering at Portal Instruments, will be exploring the possibilities in the upcoming Pharmapack 2018 presentation, “Needle-free injectors: considerations for adopting next gen technology.” Portal has developed a needle-free injector based off jet-injector technology, which is essentially a high-speed jet of drug that is much smaller than a needle and can deliver up to 1 mL to the subcutaneous...
Source: MDDI - January 24, 2018 Category: Medical Devices Authors: Daphne Allen Tags: Medical Device Business Source Type: news

Death Rate Falls with Anti-TNF in Crohn's (CME/CE)
(MedPage Today) -- Reduced mortality seen primarily in patients with comorbidities (Source: MedPage Today Gastroenterology)
Source: MedPage Today Gastroenterology - January 24, 2018 Category: Gastroenterology Source Type: news

Opioids Overused for Functional GI Pain (CME/CE)
(MedPage Today) -- Opioid use ill-advised for war vets with unexplained GI symptoms (Source: MedPage Today Gastroenterology)
Source: MedPage Today Gastroenterology - January 24, 2018 Category: Gastroenterology Source Type: news

Acute Liver Failure Induced by Idiosyncratic Drug Reactions Acute Liver Failure Induced by Idiosyncratic Drug Reactions
Review the diagnostic and therapeutic challenges of idiosyncratic drug-induced liver injury, a rare cause of acute liver failure. Which drugs are commonly implicated, and how can outcomes be improved?Liver International (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - January 24, 2018 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

Dirty Water Takes Toll on American Health, Wallets
Water-related recreational activities lead to more than 90 million cases a year of gastrointestinal, respiratory, ear, eye and skin-related illnesses in the United States, according to the study (Source: WebMD Health)
Source: WebMD Health - January 23, 2018 Category: Consumer Health News Source Type: news

Combo Therapy Doubles PFS in Unresectable HCC
(MedPage Today) -- Chemoembolization plus sorafenib tops embolization alone (Source: MedPage Today Gastroenterology)
Source: MedPage Today Gastroenterology - January 23, 2018 Category: Gastroenterology Source Type: news

The Case Against Juice Is Stronger Than Ever
Juice is the health trend that just won’t go away. There’s a juicing shop on practically every city block, and everyone from your Spin instructor to your mother downs glasses of it daily. There’s no doubt that juicing is ubiquitous—but is it as healthy as everyone says? Juice can help you consume more vitamins and minerals, and that’s a positive for people who struggle to eat enough fruits and vegetables. But experts say it may not deserve its health halo. In a paper published last winter in the Journal of the American College of Cardiology, experts scrutinized several nutrition-hyped foods&md...
Source: TIME: Health - January 23, 2018 Category: Consumer Health News Authors: Jamie Ducharme Tags: Uncategorized Diet/Nutrition green juice healthytime juice cleanse Juicing onetime smoothies Weight loss Source Type: news

Swallowable Device Can Test for DNA Markers of Barrett ’ s
Biomarker - based non - endoscopic method detects BE based on methylated CCNA1 and VIM DNA (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - January 23, 2018 Category: Cancer & Oncology Tags: Gastroenterology, Oncology, Pathology, Journal, Source Type: news

TECHLAB Receives FDA 510(k) Clearance To Market CAMPYLOBACTER QUIK CHEK(TM) and CAMPYLOBACTER CHEK(TM) Tests
Tests Help Clinicians Diagnose Diarrhea Caused by Campylobacter Bacteria BLACKSBURG, Va., Jan. 23, 2018 -- (Healthcare Sales & Marketing Network) -- TECHLAB, Inc., a leading developer and manufacturer of rapid non-invasive diagnostic tests for gastroin... Diagnostics, Gastroenterology, Product Launch TECHLAB, CAMPYLOBACTER, QUIK CHEK (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 23, 2018 Category: Pharmaceuticals Source Type: news

Dirty Water Taking Toll on Americans' Health, Wallets
TUESDAY, Jan. 23, 2018 -- Water pollution is damaging Americans'health, and at a high financial cost, too, new research finds. Water-related recreational activities lead to more than 90 million cases a year of gastrointestinal, respiratory, ear,... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - January 23, 2018 Category: General Medicine Source Type: news

Ibuprofen pill claims to cut side-effects and be faster
British company infirst Healthcare have come up with a solution that could allow people in chronic pain to consume ibuprofen and get the same relief with half the dose and no risk of gastric bleeding. (Source: the Mail online | Health)
Source: the Mail online | Health - January 22, 2018 Category: Consumer Health News Source Type: news

Immunotherapy Combo Active in High-Risk CRC
(MedPage Today) -- Disease control in 80% with nivolumab-ipilimumab (Source: MedPage Today Gastroenterology)
Source: MedPage Today Gastroenterology - January 22, 2018 Category: Gastroenterology Source Type: news

Judge Orders New Olympus Trial Over Superbug Death Judge Orders New Olympus Trial Over Superbug Death
A Seattle judge said Olympus Corp. failed to properly disclose internal emails that raised safety concerns about a redesigned medical scope as early as 2008, several years before the device was publicly tied to deadly superbug outbreaks.Kaiser Health News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - January 22, 2018 Category: Consumer Health News Tags: Gastroenterology News Source Type: news

Elderly UC Patients Do Well with Extended-release Budesonide
(MedPage Today) -- No differences seen by gender in either effectiveness or safety (Source: MedPage Today Gastroenterology)
Source: MedPage Today Gastroenterology - January 22, 2018 Category: Gastroenterology Source Type: news